JOHNSON & JOHNSON (JNJ) earnings date, results and what the price requires
NYSE · SEC CIK 0000200406 · SEC filings checked Oct 16, 2026
Next report
Not yet known
Fewer than three past results filings to estimate from.
Last close
—
No closing price available.
Trailing diluted EPS
$8.61
Sum of quarters ending Jun 28, 2026, Mar 29, 2026, Dec 28, 2025, Sep 28, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Sep 27, 2026 | Oct 13, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Jun 28, 2026 | Jul 15, 2026 | $25.31B | $5.53B | $2.27 | Filing |
| Mar 29, 2026 | Apr 14, 2026 | $24.06B | $5.24B | $2.14 | Filing |
| Dec 28, 2025 | Jan 21, 2026 | $24.56B | $5.12B | $2.08 | Filing |
| Sep 28, 2025 | Oct 14, 2025 | $23.99B | $5.15B | $2.12 | Filing |
| Jun 29, 2025 | Jul 16, 2025 | $23.74B | $5.54B | $2.29 | Filing |
| Mar 30, 2025 | Apr 15, 2025 | $21.89B | $11.00B | $4.54 | Filing |
| Dec 29, 2024 | Jan 22, 2025 | $22.52B | $3.43B | $1.41 | Filing |
| Sep 29, 2024 | Oct 15, 2024 | $22.47B | $2.69B | $1.11 | Filing |
What would JOHNSON & JOHNSON have to report for its valuation to change?
No recent closing price is available for this ticker. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.